Market Insights

Under the most optimistic scenario, the loss would be at least $53 billion.

Global issues such as the pandemic, trade restrictions and climate change will increase the potential for drug shortages.

Recent research has found a 400% increase in virtual visits to physicians and other providers since the pandemic began early in 2020.

The Bureau of Economic Analysis's initial estimates show a 2% decline over 2019, or about $75.8 billion.

Despite advances in the past year, more work remains, including in the areas of personalized care plans, improved outcomes and cost containment.

Dental care, routine checkups and screenings, general doctor and specialist visits and immunizations were most commonly delayed.